Gold nanoparticles downregulate VEGF-and IL-1β-induced cell proliferation through Src kinase in retinal pigment epithelial cells

Experimental Eye Research

Volumn 91, Issue 5, 2010, Pages 769-778

  Karthikeyan, Bose ^a   Kalishwaralal, Kalimuthu ^a   Sheikpranbabu, Sardarpasha ^a   Deepak, Venkataraman ^a   Haribalaganesh, Ravinarayanan ^a   Gurunathan, Sangiliyandi ^a  

^a KALASALINGAM UNIVERSITY   (India)

Author keywords

Au NP; IL 1 ; Proliferative vitreo retinopathy; Src kinase; VEGF

Indexed keywords

GOLD; INTERLEUKIN 1BETA; NANOPARTICLE; PROTEIN TYROSINE KINASE; VASCULOTROPIN; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; GOLD CHLORIDE; GOLD DERIVATIVE; METAL NANOPARTICLE; PYRIMIDINE DERIVATIVE; VASCULOTROPIN A;

ANIMAL CELL; ARTICLE; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL SPREADING; CELL VIABILITY; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME PHOSPHORYLATION; IN VITRO STUDY; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; ANIMAL; CATTLE; CELL CULTURE; CELL MOTION; CELL SURVIVAL; CYTOLOGY; DOSE RESPONSE; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSFECTION; METABOLISM; PHOSPHORYLATION; PLASMID; VITREORETINOPATHY;

ANIMALS; CATTLE; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GOLD COMPOUNDS; INTERLEUKIN-1BETA; METAL NANOPARTICLES; PHOSPHORYLATION; PLASMIDS; PYRIMIDINES; RETINAL PIGMENT EPITHELIUM; SRC-FAMILY KINASES; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREORETINOPATHY, PROLIFERATIVE;

EID: 78049509818     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2010.09.003     Document Type: Article

References (50)

1. Alexander J.P., Bradley J.M., Gabourel J.D., Acott T.S. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 1990, 31:2520-2528.
2. Araiz J.J., Refojo M.F., Arroyo M.H., Leong F.L., Albert D.M., Tolentino F.I. Anti-proliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy. Invest. Ophthalmol. Vis. Sci. 1993, 34:522-530.
3. Bando H., Ikuno Y., Hori Y., Sayanagi K., Tano Y. Mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI3K) pathways differently regulate retinal pigment epithelial cell-mediated collagen gel contraction. Exp. Eye Res. 2006, 82:529-537.
4. Blankenship G.W. Evaluation of a single intravitreal injection of 5-fluorouracil in vitrectomy cases. Graefe's Arch. Clin. Exp. Ophthalmol. 1989, 227:565-568.
5. Brown M.T., Cooper J.A. Regulation, substrates and functions of src. Biochim. Biophys. Acta 1996, 1287:121-149.
6. Campochiaro P.A. Pathogenic mechanisms in proliferative vitreoretinopathy. Arch. Ophthalmol. 1997, 115:237-241.
7. Campochiaro P.A. Pathogenesis of proliferative vitreoretinopathy. Retina 2001, 3:2221-2227.
8. Caruthers S.D., Wickline S.A., Lanza G.M. Nanotechnological applications in medicine. Curr. Opin. Biotechnol. 2007, 18:26-30.
9. Chang C.W., Roque R.S., Defoe D.M., Caldwell R.B. An improved method for isolation and culture of pigment epithelial cells from rat retina. Curr. Eye Res. 1991, 10:1081-1086.
10. Charteris D.G., Sethi C.S., Lewis G.P., Fisher S.K. Proliferative vitreo retinopathy developments in adjunctive treatment and retinal pathology. Eye 2002, 16:369-374.
11. Chen Y.S., Hackett S.F., Schoenfeld C.L., Vinores M.A., Vinores S.A., Campochiaro P.A. Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes. Br. J. Ophthalmol. 1997, 81:919-926.
12. 5 mediates epidermal growth factor-induced retinal pigment epithelial cell proliferation and migration. Pathobiology 2010, 77:88-95.
13. Davis J.L., Jalkh A.E., Roberge F., Caspi R., Flynn H.W., Schepens C.L., Nussenblatt R.B. Subretinal fluid from human retinal detachment contains interleukin-1. Invest. Ophthalmol. Vis. Sci. 1988, 29:396.
14. Dieudonne S.C., La Heij E.C., Diederen R.M., Kessels A.G., Liem A.T., Kijlstra A., Hendrikse F. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy. Ophthalmic Res. 2007, 39:148-154.
15. Eibl K.H., Kook D., Priglinger S., Haritoglu C., Yu A., Kampik A., Welge-Lussen U. Inhibition of human retinal pigment epithelial cell attachment, spreading, and migration by alkylphosphocholines. Invest. Ophthalmol. Vis. Sci. 2006, 47:364-370.
16. Eliceiri B.P., Paul R., Schwartzberg P.L., Hood J.D., Leng J., Cheresh D.A. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Mol. Cell 1999, 4:915-924.
17. Elner S.G., Elner V.M., Jaffe G.J., Stuart A., Kunkel S.L., Strieter R.M. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr. Eye Res. 1995, 14:1045-1053.
18. Fabio R., Zanetti A., Sironi M., Polentarutti N., Lanfrancone L., Dejana E., Colotta F. Inhibition of anchorage-dependent cell spreading triggers apoptosis in cultured human endothelial cells. J. Cell Biol. 1994, 127:537-546.
19. Ghosh P., Han G., Mrinmoy De., Kim C.K., Rotello V.M. Gold nanoparticles in delivery applications. Adv. Drug Deliv. Rev. 2008, 60:1307-1315.
20. Guerrin M., Moukadiri H., Chollet P. Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J. Cell. Physiol. 1995, 164:385-394.
21. Hansen L.K., Mooney D.J., Vacanti J.P., Ingber D.E. Integrin binding and cell spreading on extracellular matrix act at different points in the cell cycle to promote hepatocyte growth. Mol. Biol. Cell 1994, 5(9):967-975.
22. Hiscott P., Sheridan C., Magee R.M., Grierson I. Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog. Retin. Eye Res. 1999, 18:167-190.
23. Hunt R.C., Fox A., Pakalnis V.A., Sigel M.M. Cytokines cause cultured retinal pigment epithelial cells to secrete metalloproteinases and to contract collagen gels. Invest. Ophthalmol. Vis. Sci. 1993, 34:3179-3186.
24. Kalishwaralal K., Deepak V., Ram Kumar Pandian S., Gurunathan S. Biological synthesis of gold nanocubes from Bacillus licheniformis. Bioresour. Technol. 2009, 100(21):5356-5358.
25. Kalishwaralal K., Deepak V., Ram Kumar Pandian S., Kottaisamy M., BarathmaniKanth S., Kartikeyan B., Gurunathan S. Biosynthesis of silver and gold nanoparticles using Brevibacterium casei. Colloids Surf. B. Biointerfaces 2010, 77(2):257-262.
26. Khawly J., Saloupis P., Hatchell D., Machemer R. Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy. Graefe's Arch. Clin. Exp. Ophthalmol. 1991, 229:464-467.
27. Kim J.H., Kim J.H., Kim K.W., Kim M.H., Yu Y.S. Intravenously administered gold nanoparticles pass through the blood-retinal barrier depending on the particle size, and induce no retinal toxicity. Nanotechology 2009, 20. 505-101.
28. Kon C.H., Occleston N.L., Aylward G.W., Khaw P.T. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study. Invest. Ophthalmol. Vis. Sci. 1999, 40:705-712.
29. Kosnosky W., Li T.H., Pakalnis V.A., Fox A., Hunt R.C. Interleukin-1-beta changes the expression of metalloproteinases in the vitreous humor and induces membrane formation in eyes containing preexisting retinal holes. Invest. Ophthalmol. Vis. Sci. 1994, 35:4260-4267.
30. Kutty R.K., Kutty G., Hooks J.J., Wiggert B., Nagineni C.N. Transforming growth factorbeta inhibits the cytokine-mediated expression of the inducible nitric oxide synthase mRNA in human retinal pigment epithelial cells. Biochem. Biophys. Res. Commun. 1995, 215:386-393.
31. Lee J.J., Park J.K., Kim Y.T., Kwon B.M., Kang S.G., Yoo Y.D., Yu Y.S., Chung H. Effect of 20-benzoyl-oxycinnamaldehyde on RPE cells in vitro and in an experimental proliferative vitreoretinopathy model. Invest. Ophthalmol. Vis. Sci. 2002, 43:3117-3124.
32. Liou G.I., Pakalnis V.A., Matragoon S., Samuel S., Behzadian M.A., Baker J., Khalil I.E., Roon P., Caldwell R.B., Hunt R.C., Marcus D.M. HGF regulation of RPE proliferation in an IL-1beta/retinal hole-induced rabbit model of PVR. Mol. Vis. 2002, 208:494-501.
33. Marmor M.F. Retinal Pigment Epithelium: Function and Disease 1998, Oxford Press, New York, 3-12.
34. Morales S.A., Mareninov S., Prasad P., Wadehra M., Braun J., Gordon L.K. Collagen gel contraction by ARPE-19 cells is mediated by a FAK-Src dependent pathway. Exp. Eye Res. 2007, 85:790-798.
35. Mukherjee P., Bhattacharya R., Wang P., Wang L., Basu S., Nagy J.A., Atala A., Mukhopadhyay D., Soker S. Antiangiogenic properties of gold nanoparticles. Clin. Cancer Res. 2005, 11:3530-3534.
36. Murphy T.L., Sakamoto T., Hinton D.R., Spee C., Usha G., Soriano D., Rayudo G., Ryan S.J. Migration of retinal pigment epithelium cells in vitro is regulated by protein kinase C. Exp. Eye Res. 1995, 60:683-695.
37. Nagasaki H., Shinagawa K., Mochizuki M. Risk factors for proliferative vitreoretinopathy. Prog. Retin. Eye Res. 1998, 17:77-98.
38. Nagineni C.N., Samuel W., Nagineni S., Pardhasaradhi K., Wiggert B., Detrick B., Hooks J.J. Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogen-activated protein kinases. J. Cell. Physiol. 2003, 197:453-462.
39. Osusky R., Tao L., Ryan S.J. Interleukin-1 in experimental proliferative vitreoretinopathy. Ophthalmologica 1997, 211:49-52.
40. Paciotti G.F., Myer L., Weinreich D., Goia D., Pavel N., McLaughlin R.E., Tamarkin L. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 2004, 11:169-183.
41. Pan Y., Leifert A., Ruau D., Neuss S., Bornemann J., Schmid G., Brandau W., Simon U., Jahnen-Dechent W. Size-dependent cytotoxicity of gold nanoparticles. Small 2007, 3(11):1941-1949.
42. Pierce E.A., Avery R.L., Foley E.D., Aiello L.P., Smith L.E. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc. Natl. Acad. Sci. 1995, 92:905-909.
43. Priglinger S.G., Alge C.S., Neubauer A.S., Kristin N., Hirneiss C., Eibl K., Kampik A., Welge-Lussen U. TGF-beta2-induced cell surface tissue transglutaminase increases adhesion and migration of RPE cells on fibronectin through the gelatin binding domain. Invest. Ophthalmol. Vis. Sci. 2004, 45:955-963.
44. Ryan S.J. The pathophysiology of proliferative vitreoretinopathy in its management. Am. J. Ophthalmol. 1985, 100:188-193.
45. Sheikpranbabu S., Kalishwaralal K., Venkataraman D., Eom S.H., Park J., Gurunathan S. Silver nanoparticles inhibit VEGF-and IL-1β-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells. J. Nanobiotechnol. 2009, 7:8.
46. Strauss O. The retinal pigment epithelium in visual function. Physiol. Rev. 2005, 85:845-881.
47. Stern W.H., Lewis G.P., Erickson P.A. Fluorouracil therapy for proliferative vitreoretinopathy after vitrectomy. Am. J. Ophthalmol. 1983, 96:33-42.
48. Wiedemann P. Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv. Ophthalmol. 1992, 36:373-384.
49. Yang K.J., Shin S., Piao L., Shin E., Li Y., Park K.A., Byun H.S., Won M., Hong J., Kweon G.R., Hur G.M., Seok J.H., Chun T., Brazil D.P., Hemmings B.A., Park J. Regulation of 3-phosphoinositide-dependent protein kinase-1 (PDK1) by Src involves tyrosine phosphorylation of PDK1 and Src homology 2 domain binding. J. Biol. Chem. 2008, 283:1480-1491.
50. Zhao S., Rizzolo L.J., Barnstable C.J. Differentiation and transdifferentiation of the retinal pigment epithelium. Int. Rev. Cytol. 1997, 171:225-226.